The Arab Drug Company (EGX:ADCI)
Egypt · Delayed Price · Currency is EGP 234.84
-1.60 (-0.68%)
At close: Jul 14, 2026
The Arab Drug Company Balance Sheet
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 33.05 | 79.28 | 232.72 | 50.48 | 40.28 | 46.43 |
Short-Term Investments | - | - | - | - | - | 13.88 |
Cash & Short-Term Investments | 33.05 | 79.28 | 232.72 | 50.48 | 40.28 | 60.31 |
Cash Growth | -66.89% | -65.93% | 361.00% | 25.33% | -33.21% | -17.65% |
Accounts Receivable | 194.3 | 130.06 | 71.44 | 69.72 | 54.02 | 33.56 |
Other Receivables | 74.9 | 76.36 | 48.45 | 20.11 | 28.91 | 15.54 |
Receivables | 379.72 | 287.39 | 203.53 | 173.07 | 153.86 | 142.07 |
Inventory | 293.35 | 327.72 | 236.28 | 254.09 | 224.85 | 171.7 |
Prepaid Expenses | - | - | 0.01 | - | 0.11 | 0.1 |
Other Current Assets | 0.84 | 0.74 | 0.34 | 0.41 | 0.43 | 0.93 |
Total Current Assets | 706.96 | 695.12 | 672.88 | 478.05 | 419.53 | 375.11 |
Property, Plant & Equipment | 696.98 | 616.53 | 444.4 | 193.36 | 145.5 | 59.19 |
Long-Term Investments | 2.26 | 2.26 | 2.26 | 2.26 | 2.26 | 3.24 |
Long-Term Deferred Tax Assets | 4.24 | 8.98 | 14.06 | 8.39 | 6.7 | 8.73 |
Other Long-Term Assets | - | - | -0 | - | -0 | - |
Total Assets | 1,410 | 1,323 | 1,134 | 682.07 | 573.98 | 446.27 |
Accounts Payable | 88.2 | 64.52 | 45.63 | 44.18 | 25.26 | 20.45 |
Accrued Expenses | 9.68 | 9.48 | 11.63 | 11.14 | 9.02 | 10.07 |
Short-Term Debt | 199.33 | 174.41 | 116.7 | 85.26 | 98.66 | 21.21 |
Current Portion of Long-Term Debt | 91.87 | 91.44 | 73.37 | - | - | - |
Current Income Taxes Payable | 37.04 | 48.72 | 24.42 | 6.33 | 2.41 | 24.76 |
Other Current Liabilities | 76.73 | 68.26 | 76.3 | 45.11 | 46.01 | 60.15 |
Total Current Liabilities | 502.85 | 456.83 | 348.04 | 192.03 | 181.36 | 136.63 |
Long-Term Debt | 212.04 | 245.35 | 324.88 | 103.71 | 52.41 | - |
Long-Term Leases | 6.34 | 0.96 | 2.15 | 3.1 | - | - |
Other Long-Term Liabilities | - | - | - | 0 | - | - |
Total Liabilities | 721.22 | 703.15 | 675.06 | 298.84 | 233.78 | 136.63 |
Common Stock | 120 | 120 | 60 | 60 | 60 | 60 |
Retained Earnings | 547.91 | 478.45 | 377.23 | 301.94 | 258.91 | 227.36 |
Comprehensive Income & Other | 21.3 | 21.3 | 21.3 | 21.3 | 21.3 | 22.27 |
Shareholders' Equity | 689.21 | 619.74 | 458.53 | 383.23 | 340.21 | 309.63 |
Total Liabilities & Equity | 1,410 | 1,323 | 1,134 | 682.07 | 573.98 | 446.27 |
Total Debt | 509.58 | 512.16 | 517.09 | 192.07 | 151.07 | 21.21 |
Net Cash (Debt) | -476.53 | -432.88 | -284.38 | -141.59 | -110.8 | 39.1 |
Net Cash Growth | - | - | - | - | - | -33.99% |
Net Cash Per Share | -39.71 | -36.07 | -23.70 | -11.80 | -8.18 | 2.82 |
Filing Date Shares Outstanding | 12 | 12 | 12 | 12 | 12 | 12 |
Total Common Shares Outstanding | 12 | 12 | 12 | 12 | 12 | 12 |
Working Capital | 204.11 | 238.29 | 324.84 | 286.03 | 238.17 | 238.48 |
Book Value Per Share | 57.43 | 51.65 | 38.21 | 31.94 | 28.35 | 25.80 |
Tangible Book Value | 689.21 | 619.74 | 458.53 | 383.23 | 340.21 | 309.63 |
Tangible Book Value Per Share | 57.43 | 51.65 | 38.21 | 31.94 | 28.35 | 25.80 |
Land | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 |
Buildings | 273.1 | 272.24 | 82.98 | 61.47 | 61.44 | 49.42 |
Machinery | 218.2 | 208.66 | 145.17 | 124.79 | 124.52 | 118.84 |
Construction In Progress | 410.52 | 318.45 | 372.62 | 154.6 | 101.16 | 25.73 |